Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Oligonucleotide Synthesis Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and growing focus on drug discovery
5.1.1.2. Rising usage of synthesized oligonucleotides in molecular diagnostics and clinical applications
5.1.1.3. Significant investments in pharmaceutical and biotechnology research
5.1.2. Restraints
5.1.2.1. High cost of oligonucleotides production
5.1.3. Opportunities
5.1.3.1. Improvements and advances in oligonucleotide synthesis
5.1.3.2. Strategic alliances for increasing production of oligonucleotides
5.1.4. Challenges
5.1.4.1. Complications associated with large scale oligonucleotide synthesis
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Oligonucleotide Synthesis Market, by Product
6.1. Introduction
6.2. Equipment
6.3. Linkers & Adaptor
6.4. Probes
6.5. Reagents & Consumables
6.6. Services
6.7. Synthesized Oligonucleotides

7. Oligonucleotide Synthesis Market, by Type
7.1. Introduction
7.2. Custom
7.3. Pre-designed

8. Oligonucleotide Synthesis Market, by Application
8.1. Introduction
8.2. Diagnostic
8.3. Research
8.4. Therapeutic

9. Oligonucleotide Synthesis Market, by End-User
9.1. Introduction
9.2. Academic Research Institutes
9.3. CROs & CMOs
9.4. Diagnostic Laboratories & Hospitals
9.5. Pharmaceutical & Biotechnology Companies

10. Americas Oligonucleotide Synthesis Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Oligonucleotide Synthesis Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Oligonucleotide Synthesis Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. UK Partnership Set To Revolutionize Oligonucleotide Manufacture
13.3.1.2. Aurisco Collaborates With Cytiva To Build First Oligo Flexfactory In China
13.3.2. New Product Launch & Enhancement
13.3.2.1. Codexis Unveils ECO Synthesis Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
13.3.3. Investment & Funding
13.3.3.1. CatSci Invests In Oligonucleotides Capability For Rare Diseases
13.3.4. Award, Recognition, & Expansion
13.3.4.1. GenScript Expands Peptide and Oligonucleotide Production Facility in China
13.3.4.2. CordenPharma Announces Entry into Oligonucleotide Manufacturing with Two-phase Investment at CordenPharma Colorado2nd May 2023
13.3.4.3. Oligo Factory Opens New State-of-the-Art Oligo Manufacturing Facility
13.3.4.4. Agilent Will Double Oligonucleotide Capacity
13.3.4.5. WuXi STA Opens Large-Scale Oligo and Peptide Manufacturing Facility

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Agilent Technologies, Inc.
14.1.2. Ajinomoto Bio-Pharma Services
14.1.3. ATDBio Ltd.
14.1.4. Bio-synthesis Inc.
14.1.5. Biocomma Ltd.
14.1.6. Biolegio B.V.
14.1.7. Biolytic Lab Performance Inc.
14.1.8. Bioserve India by Reprocell Group
14.1.9. Bon Opus Biosciences, LLC
14.1.10. Creative Biogene
14.1.11. Cusabio Technology LLC
14.1.12. Danaher Corporation
14.1.13. Eurofins Genomics LLC
14.1.14. Eurogentec S.A. by Kaneka Corporation
14.1.15. GE Healthcare Inc.
14.1.16. Generi Biotech
14.1.17. Genscript Corporation
14.1.18. Hongene Biotech Corp.
14.1.19. LGC Genomics Limited
14.1.20. Merck KGaA
14.1.21. Microsynth AG
14.1.22. Nitto Denko Avecia Inc.
14.1.23. Novartis AG
14.1.24. Perkin Elmer
14.1.25. SLS Research Pvt Ltd.
14.1.26. Synbio Technologies
14.1.27. TAG Copenhagen A/S
14.1.28. TCI Chemicals (India) Pvt. Ltd.
14.1.29. Thermo Fisher Scientific Inc.
14.1.30. TriLink BioTechnologies, Inc.
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2023 VS 2030
FIGURE 3. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. OLIGONUCLEOTIDE SYNTHESIS MARKET DYNAMICS
FIGURE 7. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LINKERS & ADAPTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 13. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CUSTOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRE-DESIGNED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CROS & CMOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. THAILAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. EGYPT OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NORWAY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. POLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. TURKEY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 193. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. OLIGONUCLEOTIDE SYNTHESIS MARKET LICENSE & PRICING